Teva Introduces Granisetron Hydrochloride Injection in Multiple Dose Vials

June 30, 2008 – Teva Health Systems is pleased to announce the introductionand availability of Granisetron Hydrochloride Injection in 4 mL multiple dose vials. This Tevaproduct is AP rated to Kytril®* Injection. With the addition of this new size, Teva now offersGranisetron Hydrochloride Injection in 0.1 mg/mL, 1 mL vials, and 1 mg/mL, 1 mL and 4 mL vials.“Our customers look to us for a continuous supply of new health systems generics,” states JenniferGuzman, Director of Commercial Operations. “Teva’s commitment to new product developmentassures important products like Granisetron are available on a timely basis.”Teva Health Systems is a part of Teva Pharmaceuticals, the leading pharmaceutical manufacturerfor both new and total prescriptions.‡ The company has an aggressive Research and Developmenteffort and one of the best overall ANDA approval records in the industry.